Supportive Care in Cancer

, Volume 15, Issue 4, pp 357–362

A survey of National Cancer Institute-designated comprehensive cancer centers’ oral health supportive care practices and resources in the USA

  • Joel B. Epstein
  • Ira R. Parker
  • Matthew S. Epstein
  • Anurag Gupta
  • Susan Kutis
  • Daniela M. Witkowski
Supportive Care International

Abstract

Background

The oral complications and morbidity resulting from overall cancer therapy utilizing radiation, chemotherapy, and/or stem cell transplantation can have significant impact on a patient’s health, quality of life, cost of care, and cancer management. There has been minimal health services research focusing on the status of medically necessary, oral supportive services at US cancer centers.

Methods

A pre-tested, survey questionnaire was distributed to the directors of National Cancer Institute (NCI)-designated comprehensive cancer centers to assess each institution’s resource availability and clinical practices, as it relates to the prevention and management of oral complications during cancer treatment.

Results

Sixteen of the 39 comprehensive cancer centers responded to the survey. Of the respondents, 56% of the centers did not have a dental department. The sites of delivery of oral supportive care services range from the provision of in-house dental care to community-based, private practice sites. No standard protocols were in place for either oral preventive care or for supportive services for oral complications during or after cancer therapy. Fifty percent of the responding comprehensive cancer centers reported orally focused research and/or clinical trial activities.

Conclusions

Comprehensive cancer care must include an oral care component, particularly for those cancer patients who are at high risk for oral complications. This requires a functional team of oral care providers collaborating closely within the oncology team. Considering the number of cancer patients receiving aggressive oncologic treatment that may result in oral toxicity, the impact of oral conditions on a compromised host, and the potential lack of appropriate resources and healthcare personnel to manage these complications, future research efforts are needed to identify the strengths and weaknesses of present oral supportive care delivery systems at both NCI-designated cancer centers and community-based oncology practices.

Keywords

Oral/dental care Oncology Comprehensive cancer centers 

References

  1. 1.
    Epstein JB, Parker IR, Epstein MS, Stevenson-Moore P (2004) Cancer-related oral health care services and resources: a survey of oral and dental care in Canadian cancer centers. J Can Dent Assoc 70(5):302–304PubMedGoogle Scholar
  2. 2.
    Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98(7):1531–1539PubMedCrossRefGoogle Scholar
  3. 3.
    Rose-Ped A, Belim LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ (2002) Complications of radiation therapy for head and neck cancers. Cancer Nurs 25:462–467Google Scholar
  4. 4.
    Rose-Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ (2002) Complications of radiation therapy for head and neck cancers. The patient’s perspective. Cancer Nurs 25(6):461–469PubMedCrossRefGoogle Scholar
  5. 5.
    Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST (2004) Mucositis study section of the multinational association for supportive care in cancer; International Society for Oral Oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(9 Suppl):2026–2046PubMedCrossRefGoogle Scholar
  6. 6.
    Sonis ST, Oster G, Fuchs H, Belim L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FK, Horowitz M (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19(8):2201–2205PubMedGoogle Scholar
  7. 7.
    Modi BJ, Knab B, Feldman LE et al (2005) Review of current treatment practices for carcinoma of the head and neck. Expert Opin Pharmacother 6(7):1143–1155PubMedCrossRefGoogle Scholar
  8. 8.
    Barker GJ, Epstein JB, Williams KB, Gorsky M, Raber-Durlacher JE (2005) Current practice and knowledge of oral care for cancer patients: a survey of supportive health care providers. Support Care Cancer 13:32–41PubMedCrossRefGoogle Scholar
  9. 9.
    Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19):1945–1952PubMedCrossRefGoogle Scholar
  10. 10.
    Brizel DM, Albers MM, Fisher SR, Scher RL, Richtsmeier WJ, Hars V et al (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338(25):1798–1804PubMedCrossRefGoogle Scholar
  11. 11.
    Bourhis J, Calais G, Lapeyre M, Tortochaux J, Alfonsi M, Sire C et al (2004) Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC). Semin Oncol 31(6):822–826PubMedCrossRefGoogle Scholar
  12. 12.
    Cooper JS, Pajak, TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med 350(19):1937–1944PubMedCrossRefGoogle Scholar
  13. 13.
    Duncan GG, Epstein JB, Tu D, Sayed SE, Bezjak A, Ottaway J, Pater J (2005) Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head Neck 27(5):421–428PubMedCrossRefGoogle Scholar
  14. 14.
    Mignogna MD, Fedele S, Lo Russo L (2004) The World Cancer Report and the burden of oral cancer. Eur J Cancer Prev (2):139–142CrossRefGoogle Scholar
  15. 15.
    Institute of Medicine Report (1995) Dental education at the crossroads. National Academy Press, Washington, District of Columbia (2000)Google Scholar
  16. 16.
    Oral complications of cancer therapies: diagnosis, prevention and treatment (1990). NCI Monogr 9:3–8Google Scholar
  17. 17.
    US Department of Health and Human Services (2000) Oral health in America: a report of the Surgeon General. Rockville, Maryland: US Department of Health and Human Services, National Institute of Dental and Craniofacial Research, National Institutes of Health, 2–3Google Scholar
  18. 18.
    Epstein JB, Rea G, Wong FL, Spinelli J, Stevenson-Moore P (1987) Osteoradionecrosis: study of the relationship of dental extractions in patients receiving radiotherapy. Head Neck Surg 10:48–54PubMedCrossRefGoogle Scholar
  19. 19.
    McCarthy GM, Awde JD, Ghandi H, Vincent M, Kocha WI (1998) Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol 34:484–490PubMedCrossRefGoogle Scholar
  20. 20.
    McCarthy GM, Sillings JR (1992) Orofacial complications of chemotherapy for breast cancer. Oral Surg Oral Med Oral Pathol 74:172–178PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Joel B. Epstein
    • 1
    • 2
  • Ira R. Parker
    • 1
    • 3
  • Matthew S. Epstein
    • 4
  • Anurag Gupta
    • 1
  • Susan Kutis
    • 1
  • Daniela M. Witkowski
    • 1
  1. 1.Department of Oral Medicine and Diagnostic Sciences, College of DentistryUniversity of IllinoisChicagoUSA
  2. 2.Chicago Cancer Center, College of MedicineUniversity of IllinoisChicagoUSA
  3. 3.University of California, San Diego School of Medicine, Division of GeriatricsNational Conflict Resolution CenterSan DiegoUSA
  4. 4.School of Dentistry University of Washington Box 356365, D322/D323SeattleUSA

Personalised recommendations